Acute hepatic encephalopathy and multiorgan failure in sickle cell disease and COVID-19.
作者信息
Martone Giulia M, Nanjireddy Priyanka M, Craig Robin A, Prout Andrew J, Higman Meghan A, Kelly Kara M, Ambrusko Steven J
机构信息
Department of Pediatrics, John R. Oishei Children's Hospital, University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, New York.
Division of Hematology/Oncology, Department of Pediatrics, John R. Oishei Children's Hospital, Roswell Park Comprehensive Cancer Center, University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, New York.
出版信息
Pediatr Blood Cancer. 2021 May;68(5):e28874. doi: 10.1002/pbc.28874. Epub 2021 Jan 23.
Abstract
摘要
相似文献
1
Acute hepatic encephalopathy and multiorgan failure in sickle cell disease and COVID-19.镰状细胞病和新型冠状病毒肺炎并发急性肝性脑病及多器官功能衰竭
Pediatr Blood Cancer. 2021 May;68(5):e28874. doi: 10.1002/pbc.28874. Epub 2021 Jan 23.
2
Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).2019新型冠状病毒病（COVID-19）所致镰状细胞病的血管闭塞性危机和急性胸综合征
Am J Hematol. 2020 Jun;95(6):725-726. doi: 10.1002/ajh.25821. Epub 2020 Apr 21.
3
Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.2019冠状病毒病大流行期间血红蛋白异常患者的护理：建议概述
Am J Hematol. 2020 Aug;95(8):E208-E210. doi: 10.1002/ajh.25857. Epub 2020 May 21.
4
Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.新型冠状病毒肺炎感染对24例镰状细胞病患者的影响。美国密歇根州底特律市一家中心的城市经验。
Hemoglobin. 2020 Jul;44(4):284-289. doi: 10.1080/03630269.2020.1797775. Epub 2020 Jul 28.
5
Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome.托珠单抗治疗一名患有镰状细胞病和急性胸部综合征的儿童重症 COVID-19 后病情显著改善。
Am J Hematol. 2020 Aug;95(8):E192-E194. doi: 10.1002/ajh.25855. Epub 2020 May 16.
6
Acute chest syndrome in the setting of SARS-COV-2 infections-A case series at an urban medical center in the Bronx.急性胸部综合征在 SARS-CoV-2 感染中的表现——布朗克斯市一家城市医疗中心的病例系列。
Pediatr Blood Cancer. 2020 Nov;67(11):e28579. doi: 10.1002/pbc.28579. Epub 2020 Sep 7.
7
COVID-19 infection and sickle cell disease: a UK centre experience.新型冠状病毒肺炎感染与镰状细胞病：英国一家中心的经验
Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779. Epub 2020 Jun 17.
8
Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia.COVID-19 对镰状细胞贫血患者血管阻塞危象的影响。
Int J Infect Dis. 2021 May;106:128-133. doi: 10.1016/j.ijid.2021.03.044. Epub 2021 Mar 16.
9
COVID-19 and sickle cell disease in Bahrain.巴林的 COVID-19 和镰状细胞病。
Int J Infect Dis. 2020 Dec;101:14-16. doi: 10.1016/j.ijid.2020.09.1433. Epub 2020 Sep 24.
10
COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.新冠病毒肺炎作为一名成年镰状细胞病患者急性胸综合征的病因
Am J Hematol. 2020 Jul;95(7):E154-E156. doi: 10.1002/ajh.25809. Epub 2020 Apr 21.
本文引用的文献
1
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.法国巴黎新冠疫情期间儿童川崎样多系统炎症综合征：前瞻性观察研究。
BMJ. 2020 Jun 3;369:m2094. doi: 10.1136/bmj.m2094.
2
COVID-19 cytokine storm: the interplay between inflammation and coagulation.新型冠状病毒肺炎细胞因子风暴：炎症与凝血之间的相互作用
Lancet Respir Med. 2020 Jun;8(6):e46-e47. doi: 10.1016/S2213-2600(20)30216-2. Epub 2020 Apr 27.
3
COVID-19 and its implications for thrombosis and anticoagulation.新型冠状病毒肺炎及其对血栓形成和抗凝的影响。
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
4
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日，14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
5
Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).2019新型冠状病毒病（COVID-19）所致镰状细胞病的血管闭塞性危机和急性胸综合征
Am J Hematol. 2020 Jun;95(6):725-726. doi: 10.1002/ajh.25821. Epub 2020 Apr 21.
6
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.香港队列粪便样本中 SARS-CoV-2 感染的胃肠道表现及病毒载量：系统评价与荟萃分析
Gastroenterology. 2020 Jul;159(1):81-95. doi: 10.1053/j.gastro.2020.03.065. Epub 2020 Apr 3.
7
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19.血液净化疗法对降低重症COVID-19晚期并发症细胞因子风暴的潜在作用。
Clin Immunol. 2020 May;214:108408. doi: 10.1016/j.clim.2020.108408. Epub 2020 Apr 1.
8
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19.一种针对新型冠状病毒的新型治疗方法：支持对暴发性新型冠状病毒肺炎使用治疗性血浆置换的观点。
Crit Care. 2020 Apr 2;24(1):128. doi: 10.1186/s13054-020-2836-4.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias.新型冠状病毒肺炎与其他肺炎的临床特征比较研究。
Clin Infect Dis. 2020 Jul 28;71(15):756-761. doi: 10.1093/cid/ciaa247.
Zotero 插件